Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles.
about
ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozymeCrystallographic analysis of metal-ion binding to human ubiquitinCopper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxificationDetoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin195Pt NMR--theory and application.Proteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm.Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs.Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions.Cytotoxic Profile and Peculiar Reactivity with Biomolecules of a Novel "Rule-Breaker" Iodidoplatinum(II) Complex.Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1.Cisplatin affects the conformation of apo form, not holo form, of BRCA1 RING finger domain and confers thermal stability.Mass-spectrometric characterization of cisplatin binding sites on native and denatured ubiquitin.Insights into the reaction of transplatin with DNA and proteins: methionine-mediated formation of histidine-guanine trans-Pt(NH3)2 cross-links.Dissociation kinetics of the streptavidin-biotin interaction measured using direct electrospray ionization mass spectrometry analysis.Protein metalation by metal-based drugs: X-ray crystallography and mass spectrometry studies.Platinated porphyrin as a new organelle and nucleus dual-targeted photosensitizer for photodynamic therapy.Covalent adducts of melphalan with free amino acids and a model peptide studied by liquid chromatography/tandem mass spectrometry.Response from Boal and Rosenzweig to Crystallography and chemistry should always go together: a cautionary tale of protein complexes with cisplatin and carboplatin.Cisplatin increases TNF-alpha mRNA stability in kidney proximal tubule cells.Mass spectrometric analysis of ubiquitin–platinum interactions of leading anticancer drugs: MALDI versus ESI
P2860
Q27643373-E56843A5-8263-4977-BC2A-6F65BA832DD4Q27666586-0978E5E7-24A0-4A0C-BCB8-9377344C6E2BQ27684801-F5EB46F0-5F13-4E02-AD94-5D43AC44DBC0Q28484446-76C5C382-9D13-4729-B761-52F2CA8418B3Q36771360-AECDC38A-DAE4-4ED7-B755-B33853AEB0A1Q37576021-CE1471C4-B999-4B96-9ED7-BAF209109B8AQ38105454-A95CEB90-FD0B-4928-8C0A-9DFD3213F7A3Q39069003-8B9B791A-E879-447B-9668-A29E98C222A9Q39155790-1D917DD8-8E19-428B-86ED-6ADBBB3D35BFQ42820956-680EFD66-64CE-41BC-B6FB-C15A2BB0AFE1Q43537472-36D8ABDC-A28A-45BD-AA60-2B63F81EB6A6Q44963722-1F2C3F5D-B0F2-47C1-B0D4-ACB6E2E865F9Q45076859-34332676-D151-42EA-A771-6772D83CBD0FQ45740523-BD751A46-A518-45BA-8E7E-61026023B66FQ47667663-ADB3E3CC-6E42-43F6-8623-BF27483E81A6Q48205731-065071EE-688F-419F-BAE1-0042463F01B0Q53180850-A279AA4E-8019-4CBF-86B8-591B4F6CFF42Q53198697-AA3CEFBF-25C4-4CF7-AF5B-7711DC837EACQ53592843-6DA7A5E1-A5EC-4F91-90D5-9D5712910FC1Q58858960-81ECEBB4-9FB6-4CE2-AAD1-76F18A83D52B
P2860
Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Interactions of cisplatin and ...... wards biological nucleophiles.
@en
Interactions of cisplatin and ...... wards biological nucleophiles.
@nl
type
label
Interactions of cisplatin and ...... wards biological nucleophiles.
@en
Interactions of cisplatin and ...... wards biological nucleophiles.
@nl
prefLabel
Interactions of cisplatin and ...... wards biological nucleophiles.
@en
Interactions of cisplatin and ...... wards biological nucleophiles.
@nl
P2093
P1476
Interactions of cisplatin and ...... wards biological nucleophiles.
@en
P2093
Dan Gibson
Tal Peleg-Shulman
Yousef Najajreh
P304
P356
10.1016/S0162-0134(02)00362-8
P577
2002-07-01T00:00:00Z